Literature DB >> 26926380

Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.

Francois A Bethoux1, Dylan M Palfy, Matthew A Plow.   

Abstract

The Timed 25 Foot Walk (T25FW), a test of maximum walking speed on a short distance, is commonly used to monitor ambulation status and to assess treatment outcomes in multiple sclerosis (MS). The main aim of this study was to determine how walking speed on the T25FW correlates with other clinician-reported and patient-reported measures in an outpatient MS rehabilitation clinic. We analyzed cross-sectional data systematically collected during a physiatry evaluation for the management of spasticity and walking limitations. In addition to demographic variables and the Expanded Disability Status Scale (EDSS), measures of body functions [lower extremity manual muscle testing (LE MMT), lower extremity Modified Ashworth Scale, Fatigue Severity Scale, leg pain], and measures of activity and quality of life (reported frequency of falls, Incapacity Status Scale, Rivermead Mobility Index, EQ5D health questionnaire, and Patient Health Questionnaire-9 items) were administered. A multivariate regression analysis was carried out. 199 patients were included in the analysis [age 49.41 (9.89) years, disease duration 15.40 (10.22) years, EDSS score 5.6 (1.2), and T25FW speed 70.93 (44.13) cm/s]. Both EDSS and LE MMT were correlated significantly with T25FW speed (R=0.692, P<0.001). After adjusting for EDSS and LE MMT, lower T25FW speed was associated with higher Incapacity Status Scale scores (R=0.316, P<0.001), lower Rivermead Mobility Index scores (R=0.540, P<0.001), and higher frequency of falls. EQ5D and Patient Health Questionnaire-9 items were not significantly associated with T25FW speed. Our findings support the clinical relevance of the T25FW in the rehabilitation of patients with MS.

Entities:  

Mesh:

Year:  2016        PMID: 26926380      PMCID: PMC4850097          DOI: 10.1097/MRR.0000000000000157

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  42 in total

1.  Natural history of multiple sclerosis.

Authors:  G C Ebers
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

2.  Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. Reliability, validity and sensitivity to disease progression. Multiple Sclerosis Study Group.

Authors:  K Syndulko; D Ke; G W Ellison; R W Baumhefner; L W Myers; W W Tourtellotte
Journal:  Mult Scler       Date:  1996-10       Impact factor: 6.312

Review 3.  A review of the psychometric properties of generic utility measures in multiple sclerosis.

Authors:  Ayse Kuspinar; Nancy E Mayo
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 5.  Multiple sclerosis-associated fatigue.

Authors:  Lauren B Krupp; Dana J Serafin; Christopher Christodoulou
Journal:  Expert Rev Neurother       Date:  2010-09       Impact factor: 4.618

6.  Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical database.

Authors:  Deborah M Miller; Nicolas R Thompson; Jeffrey A Cohen; Robert J Fox; Jen Hartman; Kathleen Schwetz; Devon S Conway; Richard A Rudick
Journal:  Mult Scler       Date:  2014-08-11       Impact factor: 6.312

7.  Walking speed and health-related quality of life in multiple sclerosis.

Authors:  Christine G Kohn; William L Baker; Matthew F Sidovar; Craig I Coleman
Journal:  Patient       Date:  2014       Impact factor: 3.883

8.  Quantitative sensory and motor measures detect change overtime and correlate with walking speed in individuals with multiple sclerosis.

Authors:  Kathleen M Zackowski; Joseph I Wang; John McGready; Peter A Calabresi; Scott D Newsome
Journal:  Mult Scler Relat Disord       Date:  2015-01       Impact factor: 4.339

9.  Importance of an individual's evaluation of functional status for health-related quality of life in patients with multiple sclerosis.

Authors:  Miriam Gavelova; Iveta Nagyova; Jaroslav Rosenberger; Martina Krokavcova; Zuzana Gdovinova; Johan W Groothoff; Jitse P van Dijk
Journal:  Disabil Health J       Date:  2015-03-10       Impact factor: 2.554

Review 10.  The multiple sclerosis functional composite: a clinically meaningful measure of disability.

Authors:  Chris H Polman; Richard A Rudick
Journal:  Neurology       Date:  2010-04-27       Impact factor: 9.910

View more
  4 in total

1.  The feasibility of assessing cognitive and motor function in multiple sclerosis patients using robotics.

Authors:  Leif Er Simmatis; Albert Y Jin; Sean W Taylor; Etienne J Bisson; Stephen H Scott; Moogeh Baharnoori
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-10-15

2.  Upper Limb Dexterity in Patients with Multiple Sclerosis: An Important and Underrated Morbidity.

Authors:  Ricardo N Alonso; Maria B Eizaguirre; Leila Cohen; Cecilia Quarracino; Berenice Silva; Maria C Pita; Cecilia Yastremiz; Sandra Vanotti; Orlando Garcea
Journal:  Int J MS Care       Date:  2020-05-15

3.  Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.

Authors:  Robert W Motl; Jeffrey A Cohen; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn D Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

4.  The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice.

Authors:  Katrin Trentzsch; Marie Luise Weidemann; Charlotte Torp; Hernan Inojosa; Maria Scholz; Rocco Haase; Dirk Schriefer; Katja Akgün; Tjalf Ziemssen
Journal:  Front Neurosci       Date:  2020-10-26       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.